NCT02393469

Brief Summary

The Chronic Obstructive Pulmonary Disease (COPD) has shown a progressive increase of morbidity and mortality, suggesting that the lung as a single therapeutic target, has not contributed in the past 20 years, significant changes to the natural evolution of the disease. Direct treatment for systemic changes and comorbidities, in fact, the most responsible for high rates of treatment failure could mean a new hope of life for individuals with COPD. This research project characterized as interdisciplinary and multidisciplinary program will be headquartered in Pulmonary Rehabilitation of the Santa Cruz Hospital which has partnerships with local companies . Its main objective will be to analyze cardiorespiratory and functional capacity in COPD patients not rehabilitated and rehabilitated after the period from 02 to 12 months of treatment in a Pulmonary Rehabilitation program in the municipality of Santa Cruz do Sul - Rio Grande do Sul. Will be included in this survey of COPD patients who were referred to a rehabilitation program with a clinical diagnosis of disease. In research activities to assess cardiorespiratory and functional capacity of COPD, pre and post-program (02 and 12 months) are provided for Pulmonary Rehabilitation. The research subjects will also be subjected to physical exercise protocol as recommended by the GOLD (2009), a period of eight weeks, often 2x / week, where their vital signs are measured before, during and after each session. Thus, it is believed that it will be possible to refine the knowledge of mechanisms by which the judicious use of pulmonary rehabilitation can control the progression of COPD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jan 2014

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2014

Completed
7 months until next milestone

First Posted

Study publicly available on registry

March 19, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

December 3, 2015

Status Verified

December 1, 2015

Enrollment Period

2.9 years

First QC Date

September 2, 2014

Last Update Submit

December 2, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional capacity in COPD patients

    Will initially be evaluated after ten months.

Secondary Outcomes (12)

  • Ankle brachial index

    Will be assessed after the admission of patients to pulmonary rehabilitation program. will be held after admission, subsequently after two and ten months

  • Window in ischemic lower limbs

    will be evaluated after functional testing submaximal. will be held after admission, subsequently after two and ten months

  • walk test six minutes

    will be conducted to evaluate rates of ischemic window by ankle brachial index, will be held after admission, subsequently after two and ten months

  • heart rate variability

    will be held Durantes three tests: Shuttle Walk Test, test and six-minute walk incremental protocol in cycle rgometer. will be held after admission, subsequently after two and ten months

  • Shuttle Walk Test

    Will be conducted to evaluate the functional capacity of the study participants. will be held after admission, subsequently after two and ten months

  • +7 more secondary outcomes

Study Arms (3)

Group phase 1

PLACEBO COMPARATOR

Two months of education and self-management for COPD where patients know their disease, pathophysiology, treatment, exacerbation of symptoms, and better ways pharmacological treatment education will be conducted through a system of multidisciplinary lessons with professional Physiotherapists, Psychologists, Dieticians, Pharmacists , Physical Education Professionals and Doctors

Other: Education and self-management for COPD

Group phase 2

EXPERIMENTAL

Pulmonary rehabilitation for two months: The same patients enter phase 1 phase 2 performing this two months of pulmonary rehabilitation are also included new patients who participate directly in phase 2

Other: pulmonary rehabilitation

Group phase 3

EXPERIMENTAL

Pulmonary rehabilitation for ten months: Participate participants of phases 1 + 2 and 2, as well as new participants enter directly in phase 3

Other: pulmonary rehabilitation

Interventions

Exercises breathing exercises are performed on a cycle ergometer for 30 minutes, monitored by 50% of your maximum heart frequency, strengthening exercises for major muscle groups of the upper and lower limbs with charges based on 70% of one repetition maximum, muscle stretching test, and in expiratory pattern

Group phase 2Group phase 3

Two months of continuous and self management for COPD where patients know their disease, pathophysiology, treatment, exacerbation of symptoms, and better ways pharmacological treatment education will be conducted through a system of multidisciplinary lessons with professional Physiotherapists, Psychologists, Dieticians, Pharmacists , Physical Education Professionals and Doctors

Group phase 1

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients with a clinical diagnosis

You may not qualify if:

  • Motor sequelae of stroke, patients undergoing treatment for infectious diseases, musculoskeletal disorders that impede ambulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade de Santa Cruz do Sul

Santa Cruz do Sul, Rio Grande do Sul, 96815-900, Brazil

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Educational StatusSelf-Management

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsRehabilitationHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Andrea L Gonçalves da Silva, Doctor

    University of Santa Cruz do Sul

    PRINCIPAL INVESTIGATOR
  • Dulciane N Paiva, Doctor

    University of Santa Cruz do Sul

    STUDY DIRECTOR
  • Dannuey M Cardoso, Ms

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Diogo F Bordin, Academic

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Ricardo Gass, Academic

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Cássia L Goulart, Academic

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Natacha Angélica M da Fonseca, Academic

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Camila da C Niedermeyer, Academic

    University of Santa Cruz do Sul

    STUDY CHAIR
  • Lisiane L Carvalho, Msc

    University of Santa Cruz do Sul

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

September 2, 2014

First Posted

March 19, 2015

Study Start

January 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

December 3, 2015

Record last verified: 2015-12

Locations